View drug registration information details.


ItemsRegistration information
ID513
No513
Brand NameGAVISCON SUSPENSION
IngredientsSODIUM ALGINATE 500 MG, SODIUM BICARBONATE 267 MG, CALCIUM CARBONATE 160 MG
Dosage FormSUSPENSION
Primary PackagingSACHET
StorageDO NOT STORE ABOVE 30C
Shelf Life2 YEARS
Pack SizeBOX OF 12 SACHETS X 10ML
Dispensing CategoryPrescription only
ATC ClassificationA02BX
Pharmaceutical ClassANTACIDS, ANTIULCERANTS
IndicationsTREATMENT OF SYMPTOMS OF GASTRO-OESOPHAGEAL REFLUX SUCH AS ACID REGURGITATION, HEARTBURN AND INDIGESTION RELATED TO REFLUX, FOR EXAMPLE, FOLLOWING MEALS, OR DURING PREGNANCY, OR IN PATIENTS WITH SYMPTOMS RELATED TO REFLUX OESOPHAGITIS
ContraindicationsHYPERSENSITIVITY TO ACTIVE INGREDIENT, MODERATE OR SEVERE RENAL INSUFFICIENCY
Side EffectsANAPHYLACTIC REACTION, ANAPHYLACTOID REACTION, URTICARIA, BROMCHOSPASM
Unit Price
EDL No
DescriptionAN OFF WHITE SUSPENSION WITH ODOUR AND FLAVOUR OF PEPERMINT
Note
License OwnerDKSH LAOS COMPANY LIMITED
ManufacturerRECKITT BENCKISER HEALTHCARE(UK)LIMITED
CountryUNITED KINGDOM
Import Registration NoPL00063/0628
Import Registration Date2011-07-27
ActivityCERTIFICATE RELEASED
Applied Date2021-04-02
FDD Registration No01 I 5373/23
FDD Registration Date2023-01-23
Expiry Date2026-01-22

Back to drug list